FDAnews
www.fdanews.com/articles/192647-occlutech-grabs-ce-mark-for-atrial-flow-regulator

Occlutech Grabs CE Mark for Atrial Flow Regulator

September 9, 2019

Occlutech’s atrial flow regulator device has been cleared on the European market for treating heart failure symptoms through decompression.

The intra-atrial shunt is placed in the patient’s septum between the left and right atriums via a minimally invasive procedure to decompress abnormal pressure.

The device improves heart function by “maintaining the correct sizing of a created shunt,” ┬áthe company said. The device comes in a variety of sizes to allow individualized treatment.

View today's stories